Dr. Daniel S. Berman[email protected]Nuclear MedicineScreening for CAD in diabetics: Which patient? Which test?Screening for coronary artery disease (CAD) in any population is controversial. In this editorial opinion, Dr. Daniel Berman of Cedars-Sinai Medical Center points out what he believes are shortcomings in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study published this week in the Journal of the American Medical Association.April 16, 2009Page 1 of 1Top StoriesMolecular ImagingCase report: Pluvicto as a first-line treatment in late-stage prostate cancerSince 1996, the patient continually declined androgen deprivation therapy, chemotherapy, and local therapy to the prostate gland.MRINew brain MRI imaging technique could help identify Alzheimer'sRadiology EducationScholarly activity low among residency program directorsDigital X-Ray3D DEXA shows value in patients with prostate cancerSponsor ContentDigital Innovations Shaping the Future of Radiology